(TSCO) Tractor Supply - Overview
Stock: Livestock, Companion, Seasonal, Hardware, Clothing
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.69% |
| Yield on Cost 5y | 3.17% |
| Yield CAGR 5y | -18.45% |
| Payout Consistency | 100.0% |
| Payout Ratio | 44.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 31.1% |
| Relative Tail Risk | -2.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.22 |
| Alpha | -5.11 |
| Character TTM | |
|---|---|
| Beta | 0.562 |
| Beta Downside | 0.344 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.13% |
| CAGR/Max DD | 0.33 |
Description: TSCO Tractor Supply December 17, 2025
Tractor Supply Company (NASDAQ: TSCO) is the largest U.S. retailer focused on the “rural lifestyle” market, serving hobby farmers, ranchers, and pet owners through a mix of brick-and-mortar stores (Tractor Supply, Petsense, Orscheln Farm & Home) and e-commerce sites (TractorSupply.com, Petsense.com). Its product portfolio spans livestock and equine feed, companion-animal supplies, seasonal recreation items, hardware, and apparel, many sold under private-label brands such as 4health, Paws & Claws, and American Farmworks.
Key recent metrics (FY 2024) show comparable-store sales up 5.2% YoY, driven by a 3.8% rise in average basket size and a 2.1% increase in transaction frequency-both reflecting higher discretionary spending in the “home-improvement-and-outdoor” segment. The business benefits from macro trends that favor rural consumer spending: a modest but persistent rise in farm-related income (≈ 2.5% annual growth) and a low-interest-rate environment that supports purchases of higher-ticket items like tractors and power equipment. TSCO’s e-commerce share of total sales has crossed the 12% threshold, indicating a growing omnichannel footprint that is outpacing the broader specialty-retail sector’s average of 9%.
For a deeper, data-driven view of TSCO’s valuation dynamics and scenario analysis, you may find the research tools on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 1.10b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.28 > 1.0 |
| NWC/Revenue: 5.75% < 20% (prev 6.66%; Δ -0.90% < -1%) |
| CFO/TA 0.15 > 3% & CFO 1.64b > Net Income 1.10b |
| Net Debt (9.44b) to EBITDA (1.96b): 4.81 < 3 |
| Current Ratio: 1.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (530.3m) vs 12m ago -1.74% < -2% |
| Gross Margin: 33.24% > 18% (prev 0.36%; Δ 3288 % > 0.5%) |
| Asset Turnover: 149.7% > 50% (prev 151.8%; Δ -2.08% > 0%) |
| Interest Coverage Ratio: 21.22 > 6 (EBITDA TTM 1.96b / Interest Expense TTM 69.1m) |
Altman Z'' 4.67
| A: 0.08 (Total Current Assets 3.51b - Total Current Liabilities 2.61b) / Total Assets 10.93b |
| B: 0.69 (Retained Earnings 7.52b / Total Assets 10.93b) |
| C: 0.14 (EBIT TTM 1.47b / Avg Total Assets 10.37b) |
| D: 0.90 (Book Value of Equity 7.53b / Total Liabilities 8.35b) |
| Altman-Z'' Score: 4.67 = AA |
Beneish M -2.70
| DSRI: 1.20 (Receivables 27.0m/21.6m, Revenue 15.52b/14.88b) |
| GMI: 1.09 (GM 33.24% / 36.26%) |
| AQI: 1.17 (AQ_t 0.04 / AQ_t-1 0.04) |
| SGI: 1.04 (Revenue 15.52b / 14.88b) |
| TATA: -0.05 (NI 1.10b - CFO 1.64b) / TA 10.93b) |
| Beneish M-Score: -2.70 (Cap -4..+1) = A |
What is the price of TSCO shares?
Over the past week, the price has changed by +9.30%, over one month by +10.53%, over three months by +5.18% and over the past year by +6.57%.
Is TSCO a buy, sell or hold?
- StrongBuy: 10
- Buy: 5
- Hold: 16
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the TSCO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 57.8 | 3.9% |
| Analysts Target Price | 57.8 | 3.9% |
| ValueRay Target Price | 59.6 | 7.1% |
TSCO Fundamental Data Overview February 02, 2026
P/E Forward = 22.2717
P/S = 1.7318
P/B = 10.4154
P/EG = 2.1748
Revenue TTM = 15.52b USD
EBIT TTM = 1.47b USD
EBITDA TTM = 1.96b USD
Long Term Debt = 1.74b USD (from longTermDebt, two quarters ago)
Short Term Debt = 455.3m USD (from shortTermDebt, last quarter)
Debt = 9.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.44b USD (from netDebt column, last quarter)
Enterprise Value = 36.33b USD (26.89b + Debt 9.63b - CCE 194.1m)
Interest Coverage Ratio = 21.22 (Ebit TTM 1.47b / Interest Expense TTM 69.1m)
EV/FCF = 49.06x (Enterprise Value 36.33b / FCF TTM 740.5m)
FCF Yield = 2.04% (FCF TTM 740.5m / Enterprise Value 36.33b)
FCF Margin = 4.77% (FCF TTM 740.5m / Revenue TTM 15.52b)
Net Margin = 7.06% (Net Income TTM 1.10b / Revenue TTM 15.52b)
Gross Margin = 33.24% ((Revenue TTM 15.52b - Cost of Revenue TTM 10.36b) / Revenue TTM)
Gross Margin QoQ = 25.60% (prev 37.35%)
Tobins Q-Ratio = 3.32 (Enterprise Value 36.33b / Total Assets 10.93b)
Interest Expense / Debt = 0.17% (Interest Expense 16.9m / Debt 9.63b)
Taxrate = 19.04% (53.5m / 280.9m)
NOPAT = 1.19b (EBIT 1.47b * (1 - 19.04%))
Current Ratio = 1.34 (Total Current Assets 3.51b / Total Current Liabilities 2.61b)
Debt / Equity = 3.73 (Debt 9.63b / totalStockholderEquity, last quarter 2.58b)
Debt / EBITDA = 4.81 (Net Debt 9.44b / EBITDA 1.96b)
Debt / FCF = 12.75 (Net Debt 9.44b / FCF TTM 740.5m)
Total Stockholder Equity = 2.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.57% (Net Income 1.10b / Total Assets 10.93b)
RoE = 44.36% (Net Income TTM 1.10b / Total Stockholder Equity 2.47b)
RoCE = 34.81% (EBIT 1.47b / Capital Employed (Equity 2.47b + L.T.Debt 1.74b))
RoIC = 27.84% (NOPAT 1.19b / Invested Capital 4.27b)
WACC = 5.92% (E(26.89b)/V(36.52b) * Re(7.99%) + D(9.63b)/V(36.52b) * Rd(0.17%) * (1-Tc(0.19)))
Discount Rate = 7.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.28%
[DCF Debug] Terminal Value 88.27% ; FCFF base≈699.0m ; Y1≈853.5m ; Y5≈1.42b
Fair Price DCF = 59.94 (EV 41.11b - Net Debt 9.44b = Equity 31.67b / Shares 528.4m; r=5.92% [WACC]; 5y FCF grow 23.64% → 2.90% )
EPS Correlation: -74.42 | EPS CAGR: -30.13% | SUE: -1.00 | # QB: 0
Revenue Correlation: 38.41 | Revenue CAGR: 7.01% | SUE: -3.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.35 | Chg30d=-0.029 | Revisions Net=-3 | Analysts=20
EPS current Year (2026-12-31): EPS=2.19 | Chg30d=-0.145 | Revisions Net=-9 | Growth EPS=+6.2% | Growth Revenue=+5.3%
EPS next Year (2027-12-31): EPS=2.41 | Chg30d=-0.183 | Revisions Net=-7 | Growth EPS=+10.4% | Growth Revenue=+6.1%